Published in TB and Outbreaks Week, May 9th, 2000
Most patients in their study (51 of 63) treated with this combination were cured. The only variables found to be independently associated with adverse outcomes were cavitation, resistance to ofloxacin, and poor adherence (p<0.05; odds ratios = 15.9, 13.5, 12.8, respectively), they reported.
W.W. Yew and colleagues from Grantham Hospital in Hong Kong conducted a study involving 63 MDR-TB patients who had bacillary resistance to at least isoniazid and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.